http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2421212-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e33e47c8333118fb403b52bd9d023acc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a456ec019c82fbba4f3af7317a96e5c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_314ceac477d91a62d862e66a925502ce
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10
filingDate 2010-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ee87740a80abdea8044eeb2314ba525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_147b4f5150ad5f7db3144601423713db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da02cc6742b181da22afd7e6a2ce4fae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecc952ee21c3c26ad039f2ab7c4259f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5093f534a6d667e27c92eed7f5e985fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04ccdcede62e46ebcaec921292672c54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e3e1407f2ffefb114179aefcef766d6
publicationDate 2011-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2421212-C1
titleOfInvention Composition for colonic diseases
abstract FIELD: medicine, pharmaceutics. ^ SUBSTANCE: composition for colonic diseases containing a polymeric base in the form of sodium alginate and Dimexidum in the amount 6-9% is offered. The invention can be used for treatment of the terminal colonic diseases, namely hemorrhoids, rectal inflammation, proctosigmoiditis, rectal fissures, and also for prevention and treatment of radiation complications in rectal and urogenital cancers. ^ EFFECT: evident therapeutic effect of Dimexidum in synergetic action of the ingredients of the composition with no side complications after a prolonged 4-8-hour contact of an affected region of mucosa with the preparation is shown. ^ 2 ex
priorityDate 2010-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450984220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5102882

Total number of triples: 26.